Metal Toxicity and Treatment in the Integrative Oncology Setting with Maxwell Crispo, ND
This presentation is an opportunity for us to discuss metal toxicity and explore its role and treatment in the integrative oncology setting. While many may think that detoxifying “heavy metals” would be an obvious choice in complimentary cancer care, there is little to no human clinical trial data available to easily inform the appropriate application of this treatment. However, a critical appraisal and synthesis of the research that is available may help to bring more clarity to if and when this therapy should be used at all in cancer patients. We will review the clinical implications metal toxicity has on oncogenesis, as well as total health, citing the proven studied elemental metal carcinogens, as well as the carcinogenic potential of others. We will also briefly review clinical chelation research, in general. A summary of the conventional oncology treatments associated with metal toxicity will be detailed and we will discuss the various factors that should be considered when deciding whether to recommend chelation to a cancer patient. We will touch on the practical aspects of therapy, including education regarding the chelation agents that may be used, treatment protocols and desired outcomes. But more emphasis will highlight important supportive, often neglected, strategies in the detoxification process that can significantly enhance the efficacy of chelation treatment. Case studies will be used to support the ideas discussed in this presentation and to demonstrate how a clinician might approach and manage an oncology chelation patient from start to finish.
Learning Objectives
-understand the role metal toxicity can play in cancer pathogenesis, as well as in whole-systems health (with clinical relevance to the oncology patient)
-identify the types of cancer and the types of cancer treatments that metal toxicity is most commonly associated with
-evaluate and assess the type of cancer patient that is a good candidate for chelation therapy, based on a number of factors including type of cancer, cancer treatment history, stage in current cancer treatment, prognosis and comorbid conditions
-understand key chelation principles and objectives, a basic understanding of chelation protocols (what agents are used, safety and efficacy, duration, frequency, testing), and additional adjunctive treatments to support metal detoxification
-summarize the current clinical research available regarding chelation treatment and cancer and provide justification/reasoning for why this therapy is indicated
This presentation is an opportunity for us to discuss metal toxicity and explore its role and treatment in the integrative oncology setting. While many may think that detoxifying “heavy metals” would be an obvious choice in complimentary cancer care, there is little to no human clinical trial data available to easily inform the appropriate application of this treatment. However, a critical appraisal and synthesis of the research that is available may help to bring more clarity to if and when this therapy should be used at all in cancer patients. We will review the clinical implications metal toxicity has on oncogenesis, as well as total health, citing the proven studied elemental metal carcinogens, as well as the carcinogenic potential of others. We will also briefly review clinical chelation research, in general. A summary of the conventional oncology treatments associated with metal toxicity will be detailed and we will discuss the various factors that should be considered when deciding whether to recommend chelation to a cancer patient. We will touch on the practical aspects of therapy, including education regarding the chelation agents that may be used, treatment protocols and desired outcomes. But more emphasis will highlight important supportive, often neglected, strategies in the detoxification process that can significantly enhance the efficacy of chelation treatment. Case studies will be used to support the ideas discussed in this presentation and to demonstrate how a clinician might approach and manage an oncology chelation patient from start to finish.
Learning Objectives
-understand the role metal toxicity can play in cancer pathogenesis, as well as in whole-systems health (with clinical relevance to the oncology patient)
-identify the types of cancer and the types of cancer treatments that metal toxicity is most commonly associated with
-evaluate and assess the type of cancer patient that is a good candidate for chelation therapy, based on a number of factors including type of cancer, cancer treatment history, stage in current cancer treatment, prognosis and comorbid conditions
-understand key chelation principles and objectives, a basic understanding of chelation protocols (what agents are used, safety and efficacy, duration, frequency, testing), and additional adjunctive treatments to support metal detoxification
-summarize the current clinical research available regarding chelation treatment and cancer and provide justification/reasoning for why this therapy is indicated
This presentation is an opportunity for us to discuss metal toxicity and explore its role and treatment in the integrative oncology setting. While many may think that detoxifying “heavy metals” would be an obvious choice in complimentary cancer care, there is little to no human clinical trial data available to easily inform the appropriate application of this treatment. However, a critical appraisal and synthesis of the research that is available may help to bring more clarity to if and when this therapy should be used at all in cancer patients. We will review the clinical implications metal toxicity has on oncogenesis, as well as total health, citing the proven studied elemental metal carcinogens, as well as the carcinogenic potential of others. We will also briefly review clinical chelation research, in general. A summary of the conventional oncology treatments associated with metal toxicity will be detailed and we will discuss the various factors that should be considered when deciding whether to recommend chelation to a cancer patient. We will touch on the practical aspects of therapy, including education regarding the chelation agents that may be used, treatment protocols and desired outcomes. But more emphasis will highlight important supportive, often neglected, strategies in the detoxification process that can significantly enhance the efficacy of chelation treatment. Case studies will be used to support the ideas discussed in this presentation and to demonstrate how a clinician might approach and manage an oncology chelation patient from start to finish.
Learning Objectives
-understand the role metal toxicity can play in cancer pathogenesis, as well as in whole-systems health (with clinical relevance to the oncology patient)
-identify the types of cancer and the types of cancer treatments that metal toxicity is most commonly associated with
-evaluate and assess the type of cancer patient that is a good candidate for chelation therapy, based on a number of factors including type of cancer, cancer treatment history, stage in current cancer treatment, prognosis and comorbid conditions
-understand key chelation principles and objectives, a basic understanding of chelation protocols (what agents are used, safety and efficacy, duration, frequency, testing), and additional adjunctive treatments to support metal detoxification
-summarize the current clinical research available regarding chelation treatment and cancer and provide justification/reasoning for why this therapy is indicated